Puma Biotechnology (PBYI) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to -$94.4 million.
- Puma Biotechnology's Enterprise Value rose 241.61% to -$94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.4 million, marking a year-over-year increase of 241.61%. This contributed to the annual value of -$101.0 million for FY2024, which is 523.87% down from last year.
- Per Puma Biotechnology's latest filing, its Enterprise Value stood at -$94.4 million for Q3 2025, which was up 241.61% from -$96.0 million recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's Enterprise Value ranged from a high of -$60.8 million in Q2 2022 and a low of -$109.1 million during Q1 2021
- Moreover, its 5-year median value for Enterprise Value was -$93.2 million (2025), whereas its average is -$89.1 million.
- Per our database at Business Quant, Puma Biotechnology's Enterprise Value skyrocketed by 4424.96% in 2022 and then tumbled by 5047.39% in 2024.
- Puma Biotechnology's Enterprise Value (Quarter) stood at -$82.1 million in 2021, then increased by 1.26% to -$81.1 million in 2022, then decreased by 18.34% to -$95.9 million in 2023, then fell by 5.24% to -$101.0 million in 2024, then grew by 6.51% to -$94.4 million in 2025.
- Its Enterprise Value stands at -$94.4 million for Q3 2025, versus -$96.0 million for Q2 2025 and -$93.2 million for Q1 2025.